Currently there is a torrent of research on the benefits of GLP1s. This raises doubts as most are not backed by solid hypothesis. The same happened almost a century earlier when aspirin was explored as super drug. A key metric is the NNT (number needed to treat), ie how many people should take the drug for one to meet the primary goal.